Chronic kidney disease: Stemming the global tide

American Journal of Kidney Diseases

Volumn 45, Issue 1, 2005, Pages 201-208

  Nwankwo, Emeka ^a,c   Bello, Aminu K ^b   El Nahas, A Meguid ^b  

^a UNIVERSITY OF MAIDUGURI   (Nigeria)

^b Sheffield Kidney Institute   (United Kingdom)

^c SHEFFIELD TEACHING HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

BLOOD PRESSURE REGULATION; CARDIOVASCULAR DISEASE; CHRONIC KIDNEY DISEASE; DISEASE ASSOCIATION; EDITORIAL; FINANCIAL MANAGEMENT; HEALTH CARE; HEALTH PROGRAM; HUMAN; HYPERTENSION; KIDNEY FAILURE; LIFESTYLE; RISK FACTOR; SCREENING;

CHRONIC DISEASE; HUMANS; KIDNEY DISEASES; WORLD HEALTH;

EID: 11144350115     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2004.09.005     Document Type: Editorial

References (47)

1. M.J. Lysaght Maintenance dialysis population dynamics Current trends and long-term implications J Am Soc Nephrol 13 suppl 1 2002 S37 S40
2. J.L. Xue, J.Z. Ma, T.A. Louis, A.J. Collins Forecast of the number of patients with end-stage renal disease in United States to the year 2010 J Am Soc Nephrol 12 2001 2753 2758
3. F.P. Schena Epidemiology of end-stage renal disease; International comparisons Kidney Int 57 Suppl 2000 S39 S45
4. A.F. De Vecchi, M. Dratwa, M.E. Wiedmann Healthcare systems and end-stage renal disease: An international review: Costs and reimbursement/funding of ESRD therapies Nephrol Dial Transplant 14 1999 31 41
5. H.S. Trivedi, M.M. Pang, A. Campbell, P. Saab Slowing the progression of chronic renal failure Economic benefits and patients' perspectives Am J Kidney Dis 39 2002 721 729
6. J. Coresh, B.C. Astor, T. Greene, G. Eknoyan, A.S. Levey Prevalence of chronic kidney disease and decreased kidney function in the adult US population Third National Health and Nutrition Examination Survey Am J Kidney Dis 41 2003 1 12
7. R. John, M. Webb, A. Young, P.E. Stevens Unreferred chronic kidney disease A longitudinal study Am J Kidney Dis 43 2004 825 835
8. E. Ritz, W.M. McClellan Overview: Increased cardiovascular risk in patients with minor renal dysfunction: An emerging issue with far-reaching consequences J Am Soc Nephrol 15 2004 513 516
9. R.M. Henry, P.J. Kostense, G. Bos Mild renal insufficiency is associated with increased cardiovascular mortality The HOORN Study Kidney Int 62 2002 1402 1407
10. H.L. Hillege, V. Fidler, G.F. Diercks Prevention of Renal and Vascular End Stage Disease (PREVEND) Study Group Urinary albumin excretion predicts cardiovascular and non-cardiovascular mortality in general population Circulation 106 2002 1777 1782
11. R.L. Magnason, O.S. Indridason, H. Sigvaldason, N. Sigfusson, R. Palsson Prevalence and progression of CRF in Iceland A population-based study Am J Kidney Dis 40 2002 955 963
12. S.J. Chadban, E.M. Briganti, P.G. Kerr Prevalence of kidney damage in Australian adults The AusDiab Kidney Study J Am Soc Nephrol 14 suppl 2 2003 S131 S138
13. K. Iseki The Okinawa screening program J Am Soc Nephrol 14 suppl 2 2003 S127 S130
14. K. Iseki, Y. Ikemiya, C. Iseki, S. Takishita Proteinuria and the risk of developing end stage renal disease Kidney Int 63 2003 1468 1474
15. K. Iseki, Y. Ikemiya, K. Kinjo, T. Inoue, C. Iseki, S. Takishita Body mass index and the risk of development of end-stage renal disease in a screened cohort Kidney Int 65 2004 1870 1876
16. S.P. Ramirez, S.I. Hsu, W. McClellan Taking a public health approach to the prevention of end-stage renal disease The NKF Singapore Program Kidney Int 63 Suppl 2003 S61 S65
17. M.K. Mani Prevention of chronic renal failure at the community level Kidney Int 63 Suppl 2003 S86 S89
18. S.P. McDonald, G.P. Maguire, W.E. Hoy Renal function and cardiovascular risk markers in a remote Australian Aboriginal community Nephrol Dial Transplant 18 2003 1555 1561
19. C.A. Stidley, V.O. Shah, A.S. Narva A population-based, cross-sectional survey of the Zuni Pueblo A collaborative approach to an epidemic of kidney disease Am J Kidney Dis 39 2002 358 368
20. W.W. Brown, R.M. Peters, S.E. Ohmit Early detection of kidney disease in community settings. The Kidney Early Evaluation Program (KEEP) Am J Kidney Dis 42 2003 22 35
21. C.S. Fox, M.G. Larson, E.P. Leip, B. Culleton, P.W. Wilson, D. Levy Predictors of new-onset kidney disease in a community-based population JAMA 291 2004 844 850
22. M.J. Klag, P.K. Whelton, B.L. Randall, J.D. Neaton, F.L. Brancati, J. Stamler End-stage renal disease in African-Americans and white men 16-Year MRFIT findings JAMA 277 1997 1293 1298
23. P. Muntner, J. Coresh, J.C. Smith, J. Eckfeldt, M.J. Klag Plasma lipids and risk of developing renal dysfunction The Atherosclerosis Risk in Communities Study Kidney Int 58 2000 293 301
24. M.K. Haroun, B.G. Jaar, S.C. Hoffman, G.W. Comstock, M.J. Klag, J. Coresh Risk factors for chronic kidney disease A prospective study of 23,534 men and women in Washington County, Maryland J Am Soc Nephrol 14 2003 2934 2941
25. E.S. Schaeffner, T. Kurth, G.C. Curhan Cholesterol and risk of renal dysfunction in apparently healthy men J Am Soc Nephrol 14 2003 2084 2091
26. T.S. Harwell, R.G. Nelson, R.R. Little, J.M. McDowall, S.D. Helgerson, D. Gohdes Testing for microalbuminuria in 2002. Barriers to implementing current guidelines Am J Kidney Dis 42 2003 245 249
27. J. Coresh, G.L. Wei, G. McQuillan, F.L. Brancati Prevalence of high blood pressure and elevated serum creatinine level in the United States Findings from the Third National Health and Nutrition Examination Survey (1988-1994) Arch Intern Med 161 2001 1207 1216
28. S. Romundstad, J. Holmen, K. Kvenild, H. Hallan, H. Ellekjaer Microalbuminuria and all cause mortality in 2,089 apparently healthy individuals. A 4.4-year follow up study. The Nord-Trondelag Health Study (HUNT) Norway Am J Kidney Dis 42 2003 466 473
29. S. Romundstad, J. Holmen, K. Kvenild, D. Aakervik, H. Hallan Clinical relevance of microalbuminuria screening in self reported non diabetic/non-hypertensive persons identified in a large health screening--The Nord-Trondlerg Health Study (HUNT) Norway Clin Nephrol 59 2003 241 251
30. H.J. Mattix, C. Hsu, S. Shaykevich, G. Curhan Use of the albumin/creatinine ratio to detect microalbuminuria Implications of sex and race J Am Soc Nephrol 13 2002 1034 1039
31. National Kidney Foundation K/DOQI Clinical Practice Guidelines for Chronic Kidney Disease Evaluation, classification, and stratification Am J Kidney Dis 39 suppl 1 2002 S1 S246
32. W.F. Keane, G. Eknoyan Proteinuria, Albuminuria, Risk Assessment, Detection, Elimination (PARADE) A position paper of the National Kidney Foundation Am J Kidney Dis 33 1999 1004 1010
33. P.S. Topham, A. Jethwa, M. Watkins, Y. Rees, J. Feehally The value of urine screening in a young adult population Fam Pract 21 2004 18 21
34. C. Hsu, G.M. Chertow, G.C. Curhan Methodological issues in studying the epidemiology of mild to moderate chronic renal insufficiency Kidney Int 61 2002 1567 1576
35. J. Lindstrom, J.G. Eriksson, T.T. Valle Prevention of diabetes mellitus in subjects with impaired glucose tolerance in the Finnish Diabetes Prevention Study Results from a randomized clinical trial J Am Soc Nephrol 14 suppl 2 2003 S108 S113
36. M.E. Molitch, W. Fujimoto, R.F. Hamman, W.C. Knowler The Diabetes Prevention Program and its global implications J Am Soc Nephrol 14 suppl 2 2003 S103 S107
37. L.J. Appel Lifestyle modification as a means to prevent and treat high blood pressure J Am Soc Nephrol 14 suppl 2 2003 S99 S102
38. S.R. Orth, E. Ritz The renal risks of smoking An update Curr Opin Nephrol Hypertens 11 2002 483 488
39. T.V. Perneger, P.K. Whelton, I.B. Puddley, M.J. Klag Risk of end stage renal disease associated with alcohol consumption Am J Epidemiol 150 1999 1275 1281
40. T.V. Perneger, M.J. Klag, P.K. Whelton Recreational drug use A neglected risk factor for end-stage renal disease Am J Kidney Dis 38 2001 49 56
41. P. Ruggenenti, A. Schieppati, G. Remuzzi Progression, remission, and regression of chronic renal diseases Lancet 357 2001 1601 1608
42. A. Schieppati, G. Remuzzi The June 2003 Barry M. Brenner Comgan lecture. The future of renoprotection Frustration and promises Kidney Int 64 2003 1947 1955
43. National Kidney Foundation K/DOQI Clinical Practice Guidelines on Hypertension and Antihypertensive Agents in Chronic Kidney Disease Am J Kidney Dis 43 suppl 2 2004 S1 S290
44. C. Zoja, D. Corna, D. Camozzi How to fully protect the kidney in a severe model of progressive nephropathy A multidrug approach J Am Soc Nephrol 13 2002 2898 2908
45. L.F. Fried, T.J. Orchard, B.L. Kasiske Effects of lipid reduction on the progression of renal disease A meta-analysis Kidney Int 59 2001 260 269
46. A. Schieppati, G. Remuzzi Fighting renal diseases in poor countries Building a global fund with the help of the pharmaceutical industry J Am Soc Nephrol 15 2004 704 707
47. T.F. Parker, R. Blantz, T. Hostetter The Chronic Kidney Disease Initiative J Am Soc Nephrol 15 2004 708 716